Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
Lawrence Klein leads the business development, alliance management, and corporate strategy functions at CRISPR Therapeutics. In his role he oversees a team responsible for developing new strategic partnerships, fostering existing collaborations, accessing external scientific innovation, and setting the overall strategic direction for the company. He has led the establishment of multiple partnerships for the company, including the company’s co-development and co-commercialization agreement with Vertex Pharmaceuticals.
Prior to joining CRISPR Therapeutics in January 2016, Lawrence was an Associate Partner at McKinsey & Company, where he was a leader in the firm’s biotech practice, and advised pharma and biotech clients on a wide range of strategic and operational topics. Lawrence has a scientific background in the field of T-cell immunology, and earned a PhD from Stanford University in that field.